 Patricia Yoon
Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss | 6 | 2023 | 249 | 1.290 |
Why?
| | Cochlear Implantation | 3 | 2022 | 83 | 1.040 |
Why?
| | Cochlear Implants | 3 | 2022 | 96 | 1.030 |
Why?
| | Otitis Media | 6 | 2023 | 180 | 0.810 |
Why?
| | Deafness | 1 | 2020 | 78 | 0.580 |
Why?
| | Hearing Loss, Sensorineural | 3 | 2021 | 73 | 0.470 |
Why?
| | Hearing Loss, Central | 2 | 2023 | 6 | 0.370 |
Why?
| | Velopharyngeal Insufficiency | 2 | 2012 | 15 | 0.340 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.310 |
Why?
| | Social Perception | 1 | 2011 | 107 | 0.310 |
Why?
| | Professional-Patient Relations | 1 | 2011 | 154 | 0.310 |
Why?
| | Down Syndrome | 3 | 2023 | 522 | 0.300 |
Why?
| | Psychotherapy | 1 | 2011 | 190 | 0.300 |
Why?
| | Microbiota | 5 | 2023 | 782 | 0.280 |
Why?
| | Vocal Cord Paralysis | 1 | 2007 | 27 | 0.260 |
Why?
| | Ear, Middle | 5 | 2023 | 84 | 0.200 |
Why?
| | Audiometry | 2 | 2020 | 35 | 0.190 |
Why?
| | Hearing Tests | 1 | 2003 | 53 | 0.180 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 2 | 2023 | 50 | 0.180 |
Why?
| | Child | 12 | 2023 | 22600 | 0.180 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 12 | 0.170 |
Why?
| | Nasopharynx | 1 | 2022 | 73 | 0.170 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2021 | 44 | 0.170 |
Why?
| | Haemophilus Infections | 1 | 2022 | 45 | 0.170 |
Why?
| | Lymphatic System | 1 | 2001 | 15 | 0.170 |
Why?
| | Cardiac Surgical Procedures | 1 | 2007 | 609 | 0.170 |
Why?
| | Jugular Veins | 1 | 2001 | 42 | 0.170 |
Why?
| | Aneurysm | 1 | 2001 | 37 | 0.170 |
Why?
| | Plasminogen | 1 | 2020 | 27 | 0.160 |
Why?
| | Hydrocephalus | 1 | 2021 | 111 | 0.160 |
Why?
| | Palate, Soft | 2 | 2012 | 11 | 0.160 |
Why?
| | Pharynx | 2 | 2012 | 59 | 0.150 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2003 | 287 | 0.150 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 25 | 0.150 |
Why?
| | Infant | 10 | 2023 | 10023 | 0.140 |
Why?
| | Middle Ear Ventilation | 1 | 2018 | 18 | 0.140 |
Why?
| | Deoxyribonuclease I | 1 | 2018 | 41 | 0.140 |
Why?
| | Mutation, Missense | 1 | 2020 | 338 | 0.140 |
Why?
| | Equipment Failure | 1 | 2018 | 115 | 0.140 |
Why?
| | Hearing Loss, Bilateral | 1 | 2017 | 12 | 0.130 |
Why?
| | Hearing Loss, Conductive | 1 | 2017 | 24 | 0.130 |
Why?
| | Down-Regulation | 1 | 2019 | 616 | 0.120 |
Why?
| | Humans | 24 | 2023 | 144667 | 0.120 |
Why?
| | Child, Preschool | 8 | 2023 | 11790 | 0.120 |
Why?
| | Sequence Analysis, DNA | 1 | 2019 | 828 | 0.120 |
Why?
| | Hearing Aids | 1 | 2017 | 98 | 0.120 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2023 | 564 | 0.110 |
Why?
| | Treatment Outcome | 6 | 2021 | 11735 | 0.110 |
Why?
| | Membrane Proteins | 1 | 2021 | 1159 | 0.110 |
Why?
| | Pedigree | 3 | 2020 | 515 | 0.100 |
Why?
| | Postoperative Complications | 3 | 2022 | 2950 | 0.100 |
Why?
| | Genetic Variation | 1 | 2018 | 985 | 0.100 |
Why?
| | Leukemia, Megakaryoblastic, Acute | 1 | 2012 | 10 | 0.090 |
Why?
| | Male | 15 | 2023 | 72431 | 0.090 |
Why?
| | Infant, Newborn | 4 | 2023 | 6399 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1766 | 0.090 |
Why?
| | Female | 15 | 2023 | 78304 | 0.090 |
Why?
| | Mutation | 2 | 2021 | 4081 | 0.090 |
Why?
| | Neonatal Screening | 2 | 2023 | 179 | 0.080 |
Why?
| | Acoustic Impedance Tests | 2 | 2017 | 13 | 0.080 |
Why?
| | Prosthesis Design | 1 | 2011 | 355 | 0.070 |
Why?
| | Cost-Benefit Analysis | 1 | 2011 | 638 | 0.070 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2007 | 50 | 0.060 |
Why?
| | Nasal Cavity | 1 | 2006 | 62 | 0.060 |
Why?
| | Reproducibility of Results | 2 | 2020 | 3414 | 0.060 |
Why?
| | Observer Variation | 1 | 2006 | 355 | 0.060 |
Why?
| | Retrospective Studies | 5 | 2023 | 17149 | 0.060 |
Why?
| | Oval Window, Ear | 1 | 2004 | 1 | 0.050 |
Why?
| | Otosclerosis | 1 | 2004 | 5 | 0.050 |
Why?
| | Stapes Surgery | 1 | 2004 | 10 | 0.050 |
Why?
| | Auditory Threshold | 1 | 2004 | 51 | 0.050 |
Why?
| | Follow-Up Studies | 2 | 2018 | 5414 | 0.050 |
Why?
| | Endoscopy | 1 | 2006 | 317 | 0.050 |
Why?
| | Adolescent | 5 | 2023 | 22409 | 0.050 |
Why?
| | Otoacoustic Emissions, Spontaneous | 1 | 2023 | 7 | 0.050 |
Why?
| | Nasal Septum | 1 | 2003 | 30 | 0.050 |
Why?
| | Audiometry, Evoked Response | 1 | 2003 | 15 | 0.050 |
Why?
| | Mice | 4 | 2022 | 18261 | 0.050 |
Why?
| | Rhinoplasty | 1 | 2003 | 39 | 0.050 |
Why?
| | Laser Therapy | 1 | 2004 | 140 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2350 | 0.040 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 67 | 0.040 |
Why?
| | Terminology as Topic | 1 | 2003 | 255 | 0.040 |
Why?
| | Dilatation, Pathologic | 1 | 2001 | 61 | 0.040 |
Why?
| | Animals | 5 | 2022 | 37948 | 0.040 |
Why?
| | Neck | 1 | 2001 | 108 | 0.040 |
Why?
| | Young Adult | 2 | 2019 | 14122 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 51 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 79 | 0.040 |
Why?
| | Finland | 1 | 2019 | 78 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 5967 | 0.040 |
Why?
| | Quality of Life | 1 | 2011 | 3183 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 247 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 177 | 0.030 |
Why?
| | Chinchilla | 1 | 2018 | 35 | 0.030 |
Why?
| | Prospective Studies | 2 | 2018 | 7994 | 0.030 |
Why?
| | Administration, Topical | 1 | 2018 | 152 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2018 | 319 | 0.030 |
Why?
| | Exome | 1 | 2018 | 227 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 442 | 0.030 |
Why?
| | Evoked Potentials, Auditory | 1 | 2017 | 180 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 743 | 0.030 |
Why?
| | Databases, Factual | 1 | 2022 | 1494 | 0.030 |
Why?
| | Adult | 4 | 2019 | 40489 | 0.030 |
Why?
| | Middle Aged | 3 | 2019 | 35971 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2018 | 1363 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 831 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 1036 | 0.030 |
Why?
| | Mass Screening | 1 | 2022 | 1348 | 0.020 |
Why?
| | Cell Line | 1 | 2018 | 2821 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2137 | 0.020 |
Why?
| | Mastoid | 1 | 2012 | 12 | 0.020 |
Why?
| | Comorbidity | 1 | 2017 | 1652 | 0.020 |
Why?
| | Time Factors | 1 | 2003 | 7140 | 0.020 |
Why?
| | Incidence | 1 | 2017 | 2892 | 0.020 |
Why?
| | Movement | 1 | 2012 | 295 | 0.020 |
Why?
| | Prevalence | 1 | 2017 | 2839 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2591 | 0.020 |
Why?
| | Risk Factors | 1 | 2003 | 10796 | 0.020 |
Why?
| | Colorado | 1 | 2017 | 4558 | 0.020 |
Why?
| | Signal Transduction | 1 | 2019 | 5185 | 0.010 |
Why?
| | Audiometry, Pure-Tone | 1 | 2004 | 33 | 0.010 |
Why?
| | Bone Conduction | 1 | 2004 | 27 | 0.010 |
Why?
| | Cartilage | 1 | 2003 | 198 | 0.010 |
Why?
| | United States | 1 | 2019 | 16018 | 0.010 |
Why?
| | Reoperation | 1 | 2003 | 624 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2004 | 3603 | 0.010 |
Why?
| | Aged | 1 | 2004 | 25955 | 0.000 |
Why?
|
|
Yoon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|